“…The National Institutes of Health (NIH) Common Data Elements for neuropsychology also represent a step towards harmonization for U.S.-based clinical trials (Loring et al, 2011). While harmonization surveys date back nearly 30 years (Jones-Gotman & Zatorre, 1993), test consensus remains aspirational with the complications of diverse languages and cross-cultural nuances aptly recognized (Ho & Lee, 2011), even within the U.S. Thus, while there is general international consensus regarding the indications for neuropsychological assessment in routine and surgical care and the cognitive domains that should be assessed (Baxendale et al, 2019;Wilson et al, 2015), epilepsy has not been able to reach the goal of an evidence-based consensus of psychometric tests, as has been the case in other disorders, such as multiple sclerosis (Benedict et al, 2002;Benedict et al, 2012;Langdon et al, 2012), Human Immunodeficiency Virus-Acquired Immunodeficiency Syndrome (HIV-AIDS; Bottiggi et al, 2007;Butters et al, 1990), schizophrenia (Kern et al, 2008;Nuechterlein et al, 2008), vascular dementia (Wilcock et al, 2021), stroke (Hachinski et al, 2006), and Alzheimer's Disease (Weintraub et al, 2018).…”